Y10S 435/827
Actinoplanes
Y10S435/827 (Actinoplanes) appears on 59 US grants and 0 published applications in this corpus.
Search patents in Y10S- Granted patents
- 59
- Published applications
- 0
- Assignees
- 22
- Inventors
- 117
- Latest grant
- 18 Oct 2005
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 10 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 7 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Scintillation proximity assay for the detection of peptidoglycan synthesis18 Oct 2005US 6,955,886 B1AstraZeneca AB
- Diagnostic test for alzheimer's disease8 Oct 2002US 6,461,831 B1
- Gene encoding a putive efflux protein for solvents/antibiotics in Pseudomonas mendocina25 Jun 2002US 6,410,265 B1E. I. Du Pont de Nemours and Company
- Gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocina22 May 2001US 6,235,882 B1E. I. Du Pont de Nemours and Company
- Gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocina1 May 2001US 6,225,089 B1E. I. Du Pont de Nemours and Company
No published applications in this class yet.
Most cited
By later US patents
- Amino sugar derivatives58US 4,062,950 ABayer Aktiengesellschaft · 1977
- Process for applying multiple layers of a protein and a ligand extender to a surface and to the multiple-layer system56US 4,478,914 A1984
- A-21978C cyclic peptides33US 4,524,135 AEli Lilly and Company · 1985
- Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof24US 6,194,383 B1Hoechst Aktiengesellschaft · 2001
- Immunosuppressant compound23US 4,981,792 AMerck & Co., Inc. · 1991